Astrazeneca on Track for Record High Close — Data Talk
Astrazeneca PLC Sponsored ADR (AZN) is currently at $76.15, up $0.98 or 1.3%
--Would be new all-time high (Based on available data back to May 12, 1993)
--Would be the first record close since April 24, 2023, when it closed at $75.81
--Currently up eight of the past nine days
--Currently up seven consecutive days; up 11.4% over this period
--Longest winning streak since March 11, 2024, when it rose for seven straight trading days
--Best seven day stretch since the seven days ending June 24, 2022, when it rose 12.89%
--Up 12.4% month-to-date; on pace for best month since Nov. 2022, when it rose 15.58%
--Up 13.07% year-to-date
--Up 3.61% from 52 weeks ago (May 1, 2023), when it closed at $73.50
--Would be a new 52-week closing high
--Up 24.77% from its 52-week closing low of $61.03 on Feb. 13, 2024
--Traded as high as $76.58; new all-time intraday high (Based on available data back to May 12, 1993)
--Up 1.88% at today's intraday high
All data as of 9:51:40 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 29, 2024 10:10 ET (14:10 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy as Their Stories Play Out
-
Markets Brief: Return of the Meme Stocks
-
What’s Happening In the Markets This Week
-
What Does Nvidia’s Stock Split Mean for Investors?
-
It’s Been a Terrible Time for Bonds. Here’s Why You Should Own Them
-
Which AI Stocks Are Turning Hype Into Revenue?
-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
Apple: Generative AI Strategy Should Drive Sales and Upgrades
-
2 Undervalued Stocks That Just Raised Dividends
-
2 Popular Stocks That Top Managers Are Selling
-
The Best REITs to Buy
-
Nio Earnings: Revenue and Loss Largely In Line, but Vehicle Margin Missed Amid Price Competition
-
The Best Biotech Stocks to Buy
-
After Earnings, Is Marvell Stock a Buy, a Sell, or Fairly Valued?
-
Nvidia Raised Its Dividend — but There’s a Catch